An international model to predict recurrent cardiovascular disease

American Journal of Medicine

Volumn 125, Issue 7, 2012, Pages

  Wilson, Peter W F ^a   D'Agostino, Ralph ^b   Bhatt, Deepak L ^c   Eagle, Kim ^d   Pencina, Michael J ^b   Smith, Sidney C ^e   Alberts, Mark J ^f   Dallongeville, Jean ^g   Goto, Shinya ^h   Hirsch, Alan T ⁱ   Liau, Chiau Suong ^j   Ohman, E Magnus ^k   Röther, Joachim ^l   Reid, Christopher ^m   Mas, Jean Louis ⁿ   Steg, Ph Gabriel ^o  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g INSTITUT PASTEUR DE LILLE   (France)

^h TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l KLINIKUM MINDEN   (Germany)

^m MONASH UNIVERSITY   (Australia)

ⁿ CENTRE HOSPITALIER SAINTE ANNE   (France)

^o INSERM   (France)

more..

Author keywords

Acute coronary syndromes; Cardiovascular disease; Cerebrovascular disease stroke; Coronary disease; Mortality; Peripheral vascular disease; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ALGORITHM; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DIABETES MELLITUS; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PREDICTION MODEL; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SMOKING;

EID: 84862661259     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.01.014     Document Type: Article

References (22)

1. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18): 1837-1847.
2. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
3. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121(15):1768-1777.
4. Califf RM, Armstrong PW, Carver JR, et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol. 1996;27(5):1007-1019.
5. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:357-363.
6. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-298.
7. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105(3):310-315.
8. Ferrario M, Chiodini P, Chambless LE, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol. 2005; 34(2):413-421.
9. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335 (7611):136.
10. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180-187.
11. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987-1003.
12. Ohman EM, Bhatt DL, Steg PG, et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006;151(4):786.e1-786.e10.
13. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297(11):1197-1206.
14. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180-189.
15. Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010;304(12):1350-1357.
16. Cox DR. Regression models and life tables. J R Stat Soc Series B Stat Methodol. 1972;34:187-220.
17. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109-2123.
18. D'Agostino RB Sr, Nam BH. Evaluation of the performance of survival analysis models: discrimination and calibration measures. In: Balakrishnan N, Rao CR, eds. Handbook of Statistics, Volume 23: Advances in Survival Analysis. Amsteram: Elsevier; 2004:1-26.
19. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23(10):1631-1660.
20. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753.
21. von Haehling S, Lainscak M, Springer J, Anker SD. Cardiac cachexia: a systematic overview. Pharmacol Ther. 2009;121(3):227-252.
22. Beaglehole R, Epping-Jordan J, Patel V, et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet. 2008;372(9642):940-949.